Insider filing · ETRA
Carl L Gordon
Director
profile →
Electra Therapeutics, Inc.
ETRA · Healthcare · 4 filings in 24 months
ticker →
Carl L Gordon bought $3.5M of Electra Therapeutics (ETRA)
Executed Nov 3, disclosed Nov 5, 2 days later.
Value, as filed
$3.5M
458,304 sh across 8 lots
Executed
Nov 3
the trade date, as filed
Disclosed
Nov 5
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
not yet measured
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
The filer
CGCarl L Gordon (Director) filed 5 Form 4 reports in the trailing twelve months (5 purchases, 0 sales), most often in Electra Therapeutics, Inc. (ETRA). Across 4 priced purchase filings, the average 21-session return was +17.0% from execution and +14.9% from disclosure (delay-adjusted; derived). The largest single filing was $20.0M of ETRA (1,333,333 sh across 2 lots, as filed), executed Sep 21.
The name
ETRAHealthcare · Electra Therapeutics, Inc. is a clinical-stage biotechnology company
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Carl L Gordon in ETRA
ETRAPURCHASE
Electra Therapeutics, Inc.
$20.0M1,333,333 sh across 2 lots
Exec Sep 21
Filed Sep 23 · 5:35 PM ET